MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-MH-19-0049269
G Amphray Pharmaceuticals Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹54.89 Cr
▲ 13% YoY
Net profit · FY 2025
₹2.72 Cr
Net margin 4.9%
EBITDA · FY 2025
₹3.97 Cr
EBITDA margin 7.2%
Authorised capital
₹1.95 Cr
Registered with MCA
Paid-up capital
₹11 Lakh
Issued & subscribed
Company age
44 yrs
Est. 1982
Employees · EPFO
20
Provident fund records
Directors on board
3
As per MCA filings
About G Amphray Pharmaceuticals Private Limited
Data last updated:
G Amphray Pharmaceuticals Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 27 February 1982 and has been in existence for over 44 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24200MH1982PTC026504.
The company has an authorised share capital of ₹1.95 Cr and a paid-up capital of ₹11 Lakh. It is led by directors including Grace Ramu Deora and Rajiv Ramu Deora.
Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Sambava Chambers 4th Floor Sir P M Road, Mumbai, Maharashtra, India – 400001.
As per the financials filed for FY 2025, the company reported a revenue of ₹54.89 Cr, a growth of 13% compared to the previous year. For the same year it recorded a net profit of ₹2.72 Cr (net margin 4.9%) and EBITDA of ₹3.97 Cr (EBITDA margin 7.2%). Revenue has grown at a compounded annual rate (CAGR) of 28% over three years and 19% over five years.
The company has about 20 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: G. Amphray Laboratories.
G Amphray Pharmaceuticals Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-19-0049269). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website amphray.com.
Company details
CIN U24200MH1982PTC026504
Registration Number 026504
Incorporation Date 27 February 1982
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 29 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-MH-19-0049269
Recognitions & Rankings of G Amphray Pharmaceuticals
Contact details
G Amphray Pharmaceuticals Private Limited's registered office is in Mumbai, Maharashtra. Its website is amphray.com. Its e-mail address is in the company report.
- Email
- Website
- Registered AddressSambava Chambers 4th Floor Sir P M Road, Mumbai, Maharashtra, India – 400001
- IndustryPharma, API Manufacturers
To see the full contact details of G Amphray Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
G Amphray Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
G Amphray Pharmaceuticals operates one associated brand: G. Amphray Laboratories. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Bulk drugs and drug intermediates are manufactured and exported globally. | amphray.com |
Business activity
The main business activity of G Amphray Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of G Amphray Pharmaceuticals Private Limited, buy the company report.
Financials of G Amphray Pharmaceuticals Private Limited
FY 2025 filings availableG Amphray Pharmaceuticals Private Limited reported revenue of ₹54.89 Cr (up 13% YoY) for FY 2025.
Revenue · FY 2025
₹54.89 Cr ▲ 13%
Net profit · FY 2025
₹2.72 Cr margin 4.9%
EBITDA · FY 2025
₹3.97 Cr margin 7.2%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 13%
3 years · compounded
▲ 28%
5 years · compounded
▲ 19%
EBITDA CAGR growth
1 year
▼ 38%
3 years · compounded
▼ 10%
Revenue has grown at a compounded annual rate (CAGR) of 19% over five years, including 13% growth in the latest year. EBITDA fell 38% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹3.97 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2.72 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 7.2% | ||||
| Net Profit Margin | 4.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of G Amphray Pharmaceuticals Private Limited, buy the company report.
Board of directors of G Amphray Pharmaceuticals Private Limited
G Amphray Pharmaceuticals has 3 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Grace Ramu Deora Also directs: Triochem Products Limited, Triochem Laboratories Pvt Ltd, Ambernath Plasto Packaging Pvt Ltd and 1 more | Director | 03 Sep 2006 | 20 Years 1 Months | Current |
| Rajiv Ramu Deora | Director | 27 Dec 1990 | 35 Years 10 Months | Current |
| Rajesh Ramu Deora Also directs: Triochem Products Limited, Triochem Laboratories Pvt Ltd, Ambernath Plasto Packaging Pvt Ltd and 1 more | Director | 21 Jun 2005 | 21 Years 4 Months | Current |
Peer comparison
G Amphray Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (API Manufacturers, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Enal Drugs Pvt Ltd. | ₹55.27 Cr (FY 2024) | -21.0% | Hyderabad, Telangana, India | |||
| Apichem Laboratories Private Limited | ₹55.25 Cr (FY 2024) | 120.0% | Hyderabad, Telangana, India | |||
| G Amphray Pharmaceuticals Private Limitedthis company | ₹54.89 Cr (FY 2025) | ₹2.72 Cr | 4.9% | 13.0% | 20 | Mumbai, Maharashtra, India |
| Ratnamani Bio-Chemicals and Pharmaceuticlas Private Ltd | ₹54.53 Cr (FY 2024) | 6.0% | Ahmedabad, Gujarat, India | |||
| Akriti Pharmaceuticals Private Limited | ₹53.84 Cr (FY 2025) | 12.0% | Thane, Maharashtra, India |
To see the full peer comparison of G Amphray Pharmaceuticals Private Limited, buy the company report.
Auditor
G Amphray Pharmaceuticals Private Limited is audited by M L Bhuwania And Co LLP for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| M L Bhuwania And Co LLP | FY 2023 | 101484W/W100197 |
Shareholding
The shareholding of G Amphray Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of G Amphray Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving G Amphray Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for G Amphray Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
G Amphray Pharmaceuticals Private Limited has a workforce of 20 employees on its EPFO records as of Apr 06, 2024, across 1 active EPFO establishment.
Employee count
20
Active EPFO establishments
1
Employee growth
-4.76%
GST
No GST registration is on our record for G Amphray Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
G Amphray Pharmaceuticals Private Limited has 3 board changes on record since 1990: 3 appointments. The latest: Grace Ramu Deora was appointed as Director on 03 Sep 2006.
AGM
G Amphray Pharmaceuticals Private Limited last Annual general meeting of members was held on 29 Sep 2025 as per latest MCA records.
Filing
G Amphray Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Appointed
Grace Ramu Deora was appointed as Director.
Appointed
Rajesh Ramu Deora was appointed as Director.
Appointed
Rajiv Ramu Deora was appointed as Director.
Incorporation
27 Feb 1982
G Amphray Pharmaceuticals Private Limited was registered on 27 Feb 1982 with Roc Mumbai & aged 44 years 7 months as per MCA records.
Frequently asked questions
G Amphray Pharmaceuticals is an active private limited company based in Mumbai, Maharashtra, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 27 February 1982 (44+ years old) and is registered under CIN U24200MH1982PTC026504.
G Amphray Pharmaceuticals has 3 current directors:
- Grace Ramu Deora - Director
- Rajiv Ramu Deora - Director
- Rajesh Ramu Deora - Director
The latest financial statements of G Amphray Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 29 September 2025. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of G Amphray Pharmaceuticals is U24200MH1982PTC026504. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
G Amphray Pharmaceuticals was incorporated on 27 February 1982, making it 44+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of G Amphray Pharmaceuticals by revenue are Enal Drugs Pvt Ltd, Apichem Laboratories Private Limited, Ratnamani Bio-Chemicals and Pharmaceuticlas Private Ltd, Akriti Pharmaceuticals Private Limited, all in the Pharma industry (API Manufacturers, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Grace Ramu Deora was appointed as Director on 03 Sep 2006. Rajesh Ramu Deora was appointed as Director on 21 Jun 2005. Rajiv Ramu Deora was appointed as Director on 27 Dec 1990.
Yes, G Amphray Pharmaceuticals is registered as a small enterprise under Udyam registration (number: UDYAM-MH-19-0049269).
G Amphray Pharmaceuticals can be reached through the website amphray.com. Its registered office is in Mumbai, Maharashtra, India.
The registered office of G Amphray Pharmaceuticals is at Sambava Chambers 4th Floor Sir P M Road, Mumbai, Maharashtra, India – 400001.
G Amphray Pharmaceuticals operates in the pharma industry, in the api manufacturers segment.